237 related articles for article (PubMed ID: 26291546)
1. Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse.
Cochran G; Rubinstein J; Bacci JL; Ylioja T; Tarter R
J Addict Med; 2015; 9(5):411-6. PubMed ID: 26291546
[TBL] [Abstract][Full Text] [Related]
2. Prescription opioid use: Patient characteristics and misuse in community pharmacy.
Cochran G; Bacci JL; Ylioja T; Hruschak V; Miller S; Seybert AL; Tarter R
J Am Pharm Assoc (2003); 2016; 56(3):248-256.e6. PubMed ID: 27053277
[TBL] [Abstract][Full Text] [Related]
3. Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.
Cochran G; Hruschak V; Bacci JL; Hohmeier KC; Tarter R
Res Social Adm Pharm; 2017 Nov; 13(6):1055-1061. PubMed ID: 27876595
[TBL] [Abstract][Full Text] [Related]
4. Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research.
Cochran GT; Engel RJ; Hruschak VJ; Tarter RE
J Pharm Pract; 2017 Oct; 30(5):498-505. PubMed ID: 27402634
[TBL] [Abstract][Full Text] [Related]
5. Opioid medication misuse among unhealthy drinkers.
Cochran G; McCarthy R; Gordon AJ; Tarter RE
Drug Alcohol Depend; 2017 Oct; 179():13-17. PubMed ID: 28735077
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Symptoms of Prescription Opioid Misuse: Do Older Adults Differ from Younger Adult Patients?
Cochran G; Rosen D; McCarthy RM; Engel RJ
J Gerontol Soc Work; 2017; 60(6-7):443-457. PubMed ID: 28489491
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice.
Cochran G; Field C; Lawson K
J Pharm Pract; 2015 Aug; 28(4):404-12. PubMed ID: 24532819
[TBL] [Abstract][Full Text] [Related]
8. A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial.
Cochran G; Chen Q; Field C; Seybert AL; Hruschak V; Jaber A; Gordon AJ; Tarter R
Drug Alcohol Depend; 2019 Dec; 205():107570. PubMed ID: 31689641
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric comorbidity and co-occurring opioid misuse: Depression mediates the relationship between post-traumatic stress disorder and opioid misuse in community pharmacy settings.
Hruschak V; Hildenbrand AK; Cochran G
Subst Abus; 2020; 41(1):77-84. PubMed ID: 31638877
[TBL] [Abstract][Full Text] [Related]
10. A community pharmacy intervention for opioid medication misuse: A pilot randomized clinical trial.
Cochran G; Field C; Karp J; Seybert AL; Chen Q; Ringwald W; Hruschak V; Chickering S; Kincman J; Jaber A; Tarter R
J Am Pharm Assoc (2003); 2018; 58(4):395-403. PubMed ID: 29691197
[TBL] [Abstract][Full Text] [Related]
11. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
12. Opioid use patterns and risk characteristics among injured patients.
Cochran G; Pacella ML; Ringwald W; Repine M; Hruschak V; Beaugard C; Sewall C; Rosen D; Alarcon LH; Tarkin IS; Moloney GB; Corcos A
Subst Abus; 2020; 41(1):24-28. PubMed ID: 31306083
[No Abstract] [Full Text] [Related]
13. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
[TBL] [Abstract][Full Text] [Related]
14. Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions.
Rigg KK; Monnat SM
Int J Drug Policy; 2015 May; 26(5):484-91. PubMed ID: 25458403
[TBL] [Abstract][Full Text] [Related]
15. Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients prescribed opioids.
Brown JL; Cochran G; Bryan MA; Charron E; Winhusen TJ
Subst Abus; 2022; 43(1):1110-1115. PubMed ID: 35499399
[No Abstract] [Full Text] [Related]
16. Social isolation proxy variables and prescription opioid and benzodiazepine misuse among older adults in the U.S.: A cross-sectional analysis of data from the National Survey on Drug Use and Health, 2015-2017.
Day BF; Rosenthal GL
Drug Alcohol Depend; 2019 Nov; 204():107518. PubMed ID: 31494444
[TBL] [Abstract][Full Text] [Related]
17. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: A cross-sectional study.
Feingold D; Brill S; Goor-Aryeh I; Delayahu Y; Lev-Ran S
J Affect Disord; 2018 Aug; 235():293-302. PubMed ID: 29660645
[TBL] [Abstract][Full Text] [Related]
18. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
19. Screening in Trauma for Opioid Misuse Prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury.
Brown R; Deyo B; Riley C; Quanbeck A; Glass JE; Turpin R; Hetzel S; Nicholas C; Cruz M; Agarwal S
Addict Sci Clin Pract; 2017 Dec; 12(1):28. PubMed ID: 29198186
[TBL] [Abstract][Full Text] [Related]
20. Sexual Orientation Disparities in Prescription Opioid Misuse Among U.S. Adults.
Duncan DT; Zweig S; Hambrick HR; Palamar JJ
Am J Prev Med; 2019 Jan; 56(1):17-26. PubMed ID: 30467089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
